Century Therapeutics, Inc. (IPSC) Financials
IPSC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 360.7 million | 175.9 million |
2023-09-30 | 397.6 million | 178.3 million |
2023-06-30 | 417.2 million | 169.6 million |
2023-03-31 | 456.2 million | 179.1 million |
IPSC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -27.2 million | 3.6 million |
2023-09-30 | -16.9 million | 4.0 million |
2023-06-30 | -23.8 million | 3.3 million |
2023-03-31 | -34.2 million | 3.8 million |
IPSC Net Income
No data available :(
IPSC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 172.7 million | - | 48.2 million |
2023-09-30 | 169.5 million | - | 45.5 million |
2023-06-30 | 156.4 million | - | 42.0 million |
2023-03-31 | 251.5 million | - | 41.2 million |
IPSC Shares Outstanding
IPSC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 980000 | 22.3 million | 8.6 million | 3.6 million |
2023-09-30 | 3.3 million | 22.8 million | 9.0 million | - |
2023-06-30 | 4.5 million | 22.7 million | 8.2 million | - |
2023-03-31 | 5.0 million | 24.9 million | 8.9 million | - |
IPSC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 268000 | 3.6 million |
2023-09-30 | 148000 | 1.8 million |
2023-06-30 | 99000 | 2.4 million |
2023-03-31 | 1.7 million | 2.2 million |
IPSC
Price: $2.88
52 week price:
Earnings Per Share: -2.30 USD
P/E Ratio: -1.95
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 69234
Market Capitalization: 245.0 million